Abstract |
The cerebroprotective effect of prostacyclin (PGI2) was studied using the following methods: hypobaric hypoxia in mice, anoxic hypoxia in mice, complete ischemia by decapitation in mice, hypoventilation hypoxia in cats, and hypovolemic hypoxia in cats. PGI2 induced a dose-dependent prolongation of the survival time of mice, when administered either I.C.V. (0.001-10/micrograms/mice), I.V. (0.5-500/micrograms/kg), or I.P. (50-500/micrograms/kg). In the experiments on cats PGI2 (250 ng/kg/min I.V.) led to a significant improvement of the hypoxic ECoG. In another series of experiments, an interaction of some cerebroprotective agents with the anti-hypoxic effect of PGI2 was investigated. Piracetam, meclofenoxate, nicergoline, naftidrofuryl, cinnarizine, and nifedipine shifted the anti-hypoxic dose-response curve of PGI2 to the left indicating synergistic interaction. The results obtained suggest the function of PGI2 as a cerebroprotective prostanoid in brain hypoxia.
|
Authors | R Nikolov |
Journal | Biomedica biochimica acta
(Biomed Biochim Acta)
Vol. 48
Issue 2-3
Pg. S183-7
( 1989)
ISSN: 0232-766X [Print] Germany |
PMID | 2658983
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Brain Ischemia
(physiopathology)
- Cats
- Cerebral Ventricles
(drug effects, physiology, physiopathology)
- Epoprostenol
(administration & dosage, therapeutic use)
- Female
- Hypoxia, Brain
(physiopathology, prevention & control)
- Injections, Intraventricular
- Male
- Mice
- Mice, Inbred Strains
- Shock
(physiopathology, prevention & control)
|